We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

IP:NYSEInternational Paper Company Analysis

Data as of 2026-03-10 - not real-time

$39.09

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

International Paper is trading near a key support level while technical indicators signal mixed momentum. The RSI sits in the oversold region, suggesting potential short‑term bounce. However, the MACD remains bearish with the histogram below zero, reinforcing a downside bias. Beta slightly above one indicates modest sensitivity to market moves, and recent volatility has been elevated. The stock carries a high dividend yield but the payout ratio exceeds one, raising sustainability concerns. A recent downgrade to neutral by UBS and a lowered price target add to the near‑term caution.
Fundamentally, the company posted strong revenue growth but continues to generate negative earnings and a low return on equity. Debt levels are high relative to equity, creating balance‑sheet pressure despite solid operating cash flow. The discounted cash‑flow model values the shares well below the current market price, implying an overvalued valuation at present. Nevertheless, the packaging sector benefits from secular demand for renewable fiber solutions, offering a long‑term growth tailwind. With the market pricing in potential recovery, the upside to analyst targets suggests room for appreciation over a longer horizon. Investors should weigh the dividend attractiveness against earnings weakness and consider a more defensive stance in the short run.

Market Outlook

Short Term

< 1 year
Cautious
Model confidence: 5/10

Key Factors

  • bearish MACD
  • UBS downgrade to neutral
  • proximity to support level

Medium Term

1–3 years
Neutral
Model confidence: 6/10

Key Factors

  • strong revenue growth
  • high dividend yield but unsustainable
  • valuation gap with DCF

Long Term

> 3 years
Positive
Model confidence: 7/10

Key Factors

  • secular demand for renewable packaging
  • potential earnings turnaround
  • long‑term upside to analyst targets

Key Metrics & Analysis

Financial Health

Revenue Growth53.10%
Profit Margin-14.88%
P/E Ratio13.4
ROE-24.68%
ROA2.47%
Debt/Equity71.07
P/B Ratio1.4
Op. Cash Flow$1.7B
Free Cash Flow$553.2M

Technical Analysis

TrendNeutral
RSI33.0
Support$37.02
Resistance$50.25
MA 20$44.57
MA 50$43.06
MA 200$44.88
MACDBearish
VolumeStable
Fear & Greed Index76.91

Valuation

Fair Value$22.23
Target Price$46.87
Upside/Downside19.90%
GradeOvervalued
TypeBlend
Dividend Yield4.82%

Risk Assessment

Beta1.09
Volatility44.76%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskMedium
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.